Poland· PL-100317596
Mekinist
A trametinib product containing trametinibum, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Trametinib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01EE01 (trametinib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Trametinib · ATC L01EE01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of trametinib costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Trametinib · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$215.55
The record
At a glance
URPL (Poland)- Active substance
- Trametinibum
- Manufacturer
- Novartis Europharm Limited
- Country
- Poland (PL)
- ATC code
- L01EE01
- ATC class
- Trametinib
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991141844
- gtin05909991141851
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for trametinib.
Graded by severity as the source publishes them — 22 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Trametinib · interactions on record
22 records
- 22 moderate
Most severe, free to view
- FostamatinibB02BX09moderate
- ElagolixH01CC03moderate
- SarecyclineJ01AA14moderate
- IsavuconazoleJ02AC05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Trametinib in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandMekinist 2 mg, FilmtablettenNovartis Pharma Schweiz AG
- SpainMEKINIST 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
- IrelandMekinist 2 mg film-coated tabletsNovartis Europharm Limited
- IcelandMekinistNovartis Europharm Limited*
- NetherlandsMekinist 2 mg filmomhulde tabletNovartis Europharm Limited
- NorwayMekinistNovartis Europharm Limited (1)
- SwedenMekinist 2 mg Filmdragerad tablettNovartis Europharm Limited
- United KingdomMekinist 0.5mg tabletsOriginalis B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Mekinist, Spexotras
- Liechtenstein · Mekinist, Spexotras
- Norway · Mekinist, Spexotras
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/918c979f-9d1c-4b89-a1cd-d6042b815bd8 GET /v1/drugs/918c979f-9d1c-4b89-a1cd-d6042b815bd8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "2 mg",
"packaging": "05909991141844 ¦ Rpz ¦ EU/1/14/931/005 ¦ 92024\n1 butelka 7 tabl.\n05909991141851 ¦ Rpz ¦ EU/1/14/931/006 ¦ 92025\n1 butelka 30 tabl.",
"substance": "Trametinibum 2 mg",
"common_name": "Trametinibum",
"pl_product_id": "100317596",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about trametinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.